Zongzhi Z Liu (Zongzhi Liu)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Cancer research

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research (2024)
Kyeryoung Lee, Zongzhi Z Liu, Yun Mai, Tomi Jun, Meng Ma, Tongyu Wang, Lei Ai, Ediz S Calay, William K Oh, Gustavo Stolovitzky, Eric E Schadt, Xiaoyan Wang
Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation. JMIR AI 3 (2024)
Kyeryoung Lee, Zongzhi Z Liu, Yun Mai, Tomi Jun, Meng Ma, Tongyu Wang, Lei Ai, Ediz S Calay, William K Oh, Gustavo Stolovitzky, Eric E Schadt, Xiaoyan Wang
Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation. JMIR AI 3 (2024)
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research 84 (8) (2024)
Kyeryoung Lee, Zongzhi Z Liu, Yun Mai, Tomi Jun, Meng Ma, Tongyu Wang, Lei Ai, Ediz S Calay, William K Oh, Gustavo Stolovitzky, Eric E Schadt, Xiaoyan Wang
Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation. JMIR AI 3 (2024)
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research 84 (8) (2024)
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research 84 (8) (2024)
Kyeryoung Lee, Zongzhi Z Liu, Yun Mai, Tomi Jun, Meng Ma, Tongyu Wang, Lei Ai, Ediz S Calay, William K Oh, Gustavo Stolovitzky, Eric E Schadt, Xiaoyan Wang
Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation. JMIR AI 3 (2024)
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research 84 (8) (2024)
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research 84 (8) (2024)
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research 84 (8) (2024)
Kyeryoung Lee, Zongzhi Z Liu, Urmila Chandran, Iftekhar Kalsekar, Balaji Laxmanan, Mitchell K Higashi, Tomi Jun, Meng Ma, Minghao Li, Yun Mai, Christopher Gilman, Tongyu Wang, Lei Ai, Parag Aggarwal, Qi Pan, William K Oh, Gustavo Stolovitzky, Eric E Schadt, Xiaoyan Wang
Detecting Ground Glass Opacity Features in Patients With Lung Cancer: Automated Extraction and Longitudinal Analysis via Deep Learning-Based Natural Language Processing. JMIR AI 2 (2023)
Kyeryoung Lee, Zongzhi Z Liu, Urmila Chandran, Iftekhar Kalsekar, Balaji Laxmanan, Mitchell K Higashi, Tomi Jun, Meng Ma, Minghao Li, Yun Mai, Christopher Gilman, Tongyu Wang, Lei Ai, Parag Aggarwal, Qi Pan, William K Oh, Gustavo Stolovitzky, Eric E Schadt, Xiaoyan Wang
Detecting Ground Glass Opacity Features in Patients With Lung Cancer: Automated Extraction and Longitudinal Analysis via Deep Learning-Based Natural Language Processing. JMIR AI 2 (2023)
Kyeryoung Lee, Zongzhi Z Liu, Urmila Chandran, Iftekhar Kalsekar, Balaji Laxmanan, Mitchell K Higashi, Tomi Jun, Meng Ma, Minghao Li, Yun Mai, Christopher Gilman, Tongyu Wang, Lei Ai, Parag Aggarwal, Qi Pan, William K Oh, Gustavo Stolovitzky, Eric E Schadt, Xiaoyan Wang
Detecting Ground Glass Opacity Features in Patients With Lung Cancer: Automated Extraction and Longitudinal Analysis via Deep Learning-Based Natural Language Processing. JMIR AI 2 (2023)
Meiling Zhang, Zongzhi Z Liu, Keisuke Aoshima, Wesley L Cai, Hongyin Sun, Tianrui Xu, Yangyi Zhang, Yongyan An, Jocelyn F Chen, Lok Hei Chan, Asako Aoshima, Sabine M Lang, Zhen-Wei Tang, Xuanlin Che, Yao Li, Sara J Rutter, Veerle Bossuyt, Xiang Chen, Jon S Morrow, Lajos Pusztai, David L Rimm, Mingzhu Yin, Qin Yan
CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression. Science translational medicine 14 (630) (2022)